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Abstract 
Background:  To determine the frequency of co 
morbid medical disorders in the first degree 
relatives(FDRs) of probands with bipolar mood 
disorder. 
Methods: In  this descriptive study  one hundred 
bipolar probands were consecutively recruited using 
ICD-10 diagnostic criteria for Bipolar mood disorder, 
and Urdu version of Present State 
Examination.(PSE). Having recorded basic socio 
demographic details, co morbid medical disorders in 
total of 300 first degree relatives were collected by 
using Family History-Research Diagnostic Criteria 
and transferred on Performa for statistical analysis. 
Results: Out of the 300 first degree relatives of 
bipolar probands, 28.7% had medical co morbidities, 
 while 71.3% had no co-morbidity. Migraine was the 
commonest co-morbidity observed in 15% first 
degree relatives, followed by Hypertension in 9%, 
diabetes mellitus in 7% and epilepsy in 3% first 
degree relatives 
Conclusion: Co-morbid medical disorders like 
hypertension, diabetes mellitus type 2,  epilepsy and 
migraine were found  amongst the first degree 
relatives of bipolar probands.  
Key Words:  bipolar disorder, familial aggregation  
 
Introduction 
    Bipolar disorder is a chronic mental illness with a 
reported prevalence of 1% to 5%.1 It is among the 
leading causes of disability worldwide because of its 
substantial neuropsychiatric and social effects and 
medical comorbidities.2 Medical comorbidities are 
overrepresented in individuals with bipolar disorder, 
including, but not limited to, cardiovascular 
conditions, autoimmune diseases, cancer, and 
metabolic disorders. Overweight/obesity, metabolic 
syndrome, and type 2 diabetes mellitus are highly 
prevalent in individuals with bipolar disorder. 
Evidence from epidemiological studies indicates that 
medical comorbidities are responsible for significant 
morbidity and early mortality.3, 4  
     Results from studies indicate that metabolic 
comorbidities modify and complicate the clinical 
presentation of bipolar disorder. Metabolic 
comorbidities are associated with a more chronic and 
severe course of illness, as well as resistance to 
pharmacological treatment. Co-occurrence of obesity 
or type 2 diabetes mellitus and bipolar disorder has 
been suggested to contribute to cognitive dysfunction, 
a core feature of bipolar disorder and a principal 
mediator of functional disability, highlighting the 
clinical relevance of this association.5 Evidence 
suggests that amongst individuals with Bipolar mood 
disorder, the most common general medical 
comorbidities are migraine, thyroid illness, obesity, 
type 2 diabetes, and cardiovascular disease.6 McIntyre 
RS et al in their study found that individuals with 
Bipolar mood disorder were differentially affected 
with medical disorders notably hypertension (10.7%), 
asthma (6.1%), diabetes mellitus (4.3%), HIV infection 
(2.8%) and hepatitis C (1.9%).7 The high prevalence 
and substantial impact of medical comorbidities on the 
clinical outcome in bipolar disorder underscore the 
need for prioritizing the management of metabolic 
health in this clinical population.  
 
Patients and Methods  
    This cross sectional study was conducted at the 
Department of Psychiatry, Postgraduate Medical 
Centre (JPMC), Karachi, for a period of 6 months from 
May 2006 till November 2006. The total sample was 
100 patients who were consecutively recruited 
including patients of both gender aged 15 years and 
above, diagnosed with Bipolar mood disorder through 
semi-structured interviews based on ICD-10 diagnostic 
criteria for Bipolar mood disorder. Patients with severe 
cognitive impairment, with history of central nervous 
system disorders i.e temporal lobe epilepsy, and with 
acute, severe disturbance of behavior were excluded.  
 A total of 300 first degree relatives of probands with 
Bipolar mood disorder, who agreed to participate in 
the study, were inducted, having obtained informed 
written consent. The selected participants were 
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administered Family History- Research Diagnostic 
Criteria (FH-RDC), to screen them for medical co 
morbidities like Diabetes Mellitus, Hypertension, 
migraine, metabolic syndrome and epilepsy. 
Results 
   The mean age of the bipolar probands was 34.74 ± 
S.D 8.21 years with an age range of 24-60 
years.Amongst the first degree relatives of bipolar 
probands, the gender distribution amongst those 
diagnosed with psychiatric disorders revealed that 
there were 41 (13.7%) females and 62 (20.7%) males, 
with a  male:female ratio of 1.5: 1. Amongst the 300 
first degree relatives of bipolar probands,88(28.7%) 
had medical co morbidities  While 214(71.3%) had no 
co-morbidity. Migraine was the commonest co-
morbidity observed in 45(15%) first degree relatives, 
followed by Hypertension in 27(9%), Diabetes Mellitus 
in 21(7%) and epilepsy in 9 (3%) first degree relatives. 
(Table 1) 
 
Table 1 : Medical co morbidities in first degree 
relatives of bipolar probands (n=300) 
Co-morbidities Number Percentage(%) 
Migraine 45 15 
Hypertension 27 9 
Diabetes Mellitus 21 7 
Epilepsy 9 3 
 
Discussion 
     In the current study, a group of medical disorders 
in the first degree relatives of bipolar probands was 
collected through FH-RDC from the information 
provided by the proband. The main purpose was the 
identification of any medical disorder present in the 
first degree relatives of the bipolar probands. This 
study revealed that the overall frequency of type 2 
diabetes mellitus in first degree relatives of bipolar 
probands was 9%, which is a significantly higher rate 
compared to one of the local studies which found that 
in a general male population, the overall frequency of 
type 2 diabetes mellitus was 6% and for females, 
3.5%.8Though the exact mechanism of this co-
morbidity is not very clear however likely possibilities 
include genetic associations or the effect of 
psychotropic medication.9 
     Metabolic syndromes were highly prevalent among 
patients with patients with bipolar disorder.10 Regnold 
WT et al reported that abnormal glucose metabolism 
including Diabetes Mellitus Type 2 was common in 
psychiatric disorders and the rate of Diabetes Mellitus 
Type 2 was 26% in Bipolar mood disorder.11 The 
current study revealed that 9% of the first degree 
relatives had hypertension as compared to the rates in 
general population i.e 10.7%. 12 Malik R and Agha MA, 
found high prevalence rates in general population, in 
Punjab.13 First degree relatives of bipolar probands 
were found with high rates of migraine, 15%, which is 
in line with rates reported in the literature i.e 15.2%.14 
3% of the first degree relatives had been diagnosed 
with epilepsy which is a relatively much higher rate 
than the estimated rates (9.9 per 10,000) in general 
population of Pakistan.15 
Conclusion 
1.There is a high frequency of co medical disorders 
like hypertension, diabetes mellitus type 2,  epilepsy 
and migraine, amongst the first degree relatives of 
bipolar probands.  
2.Screening and early treatment of these medical co 
morbidities for better health related quality  is 
required of life of the individuals concerned. 
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